Berlin, Germany

Michael Bader

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2006-2022

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Michael Bader: A Trailblazing Innovator in Dermatological and Pharmaceutical Sciences

Introduction

Michael Bader, an accomplished inventor based in Berlin, Germany, possesses six patents that showcase his innovative contributions to the fields of dermatology and pharmacology. His groundbreaking work primarily focuses on methods for modulating pigmentation and developing novel xanthine derivatives.

Latest Patents

One of Bader's latest patents is titled "Methods for modulating pigmentation by angiotensin-converting enzyme 2 modulation." This cosmetic method involves administering an angiotensin-converting enzyme 2 (ACE2) modulator to influence pigmentation levels in subjects. The treatment can either increase pigmentation through ACE2 inhibitors or decrease it through ACE2 activators, also providing potential therapeutic avenues for inflammatory skin diseases.

Another significant patent is centered around "Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same." This invention introduces a xanthine derivative characterized by a specific chemical formula, demonstrating its effectiveness in treating serotonin-related diseases. By inhibiting tryptophan hydroxylases, these novel compounds can positively influence serotonin levels in the body.

Career Highlights

Throughout his career, Michael Bader has been associated with prestigious organizations such as the Max Delbrück Center for Molecular Medicine and the Forschungsverbund Berlin e.V. His work in these institutions has propelled his research and innovations, allowing him to make significant advancements in medical science.

Collaborations

Bader's journey has been enriched by collaborations with notable professionals, including colleagues Edgar Specker and Susann Matthes. Their partnership has likely fostered a creative environment, yielding fruitful research outcomes and paving the way for future innovations.

Conclusion

Michael Bader's inventive spirit and commitment to advancing medical science through his patents highlight his role as an influential figure in the research community. With his ongoing contributions to dermatological treatments and pharmacology, Bader continues to inspire innovation that can enhance the quality of life for many individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…